Investor's Business Daily on MSN
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results
Roche presented "unprecedented" test results for its multiple sclerosis treatment, putting pressure on key rival TG ...
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute ...
Basel: Roche has announced that it has received CE mark for its Elecsys Dengue Ag test - a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute ...
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute ...
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
Roche announced that it has received CE mark for its Elecsys Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection.
Parsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA ...
New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...
Roche Holdings AG received CE mark approval for its Elecsys Dengue Ag test, a fully automated, high-throughput immunoassay to help diagnose acute dengue virus infections. With cases of dengue on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback